Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review

被引:45
|
作者
Wilson, Lorna [1 ]
Szigeti, Attila [2 ]
Kearney, Angela [3 ]
Clarke, Mary [2 ]
机构
[1] Cluain Mhuire Community Mental Hlth Serv, Newtownpk Ave, Dublin, Ireland
[2] DETECT Early Intervent Psychosis Serv, Avila House,Carysfort Ave,Blackrock Business Pk, Dublin, Ireland
[3] St John God Hosp, Dublin, Ireland
关键词
Substance-induced psychotic disorder; Cannabis; Substance abuse; Psychopathology; Schizophrenia; Psychosis; CANNABIS-INDUCED PSYCHOSIS; SCHIZOPHRENIA-SPECTRUM DISORDERS; DRUG-ABUSE; 1ST-EPISODE PSYCHOSIS; PSYCHIATRIC-DISORDER; SYMPTOMS; ONSET; RISK; PSYCHOPATHOLOGY; MISUSE;
D O I
10.1016/j.schres.2017.11.001
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Distinguishing between a primary psychotic disorder with concurrent substance abuse (PPD + SA) and a substance-induced psychotic disorder (SIPD) can be diagnostically challenging. We aimed to determine if these two diagnoses are clinically distinct, particularly in relation to psychopathology. In addition, we aimed to examine the specific clinical features of cannabis-induced psychotic disorder (CIPD) as compared to primary psychotic disorder with concurrent cannabis abuse (PPD + CA) and also to SIPD associated with any substance. Methods: A systematic review of SIPD literature using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: Using strict inclusion criteria, a total of six studies examining SIPD were included in the review (two of which only considered psychosis induced by cannabis alone). The findings did not reveal many consistent differences in psychopathology. However, we did find that that compared to PPD + SA, individuals with SIPD have a weaker family history of psychotic disorder; a greater degree of insight; fewer positive symptoms and fewer negative symptoms; more depression (only in CIPD) and more anxiety. Conclusion: There remains a striking paucity of information on the psychopathology, clinical characteristics and outcome of SIPD. Our review highlights the need for further research in this area. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:78 / 86
页数:9
相关论文
共 50 条
  • [31] The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders
    Kelly, D. L.
    Myers, C. S.
    Abrams, M. T.
    Feldman, S.
    Park, J.
    McMahon, R. P.
    Shim, J. -C.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (04) : 1133 - 1143
  • [32] The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders
    D. L. Kelly
    C. S. Myers
    M. T. Abrams
    S. Feldman
    J. Park
    R. P. McMahon
    J.-C. Shim
    Osteoporosis International, 2011, 22 : 1133 - 1143
  • [33] Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders
    Stuyt, EB
    Sajbel, TA
    Allen, MH
    AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (02): : 166 - 173
  • [34] Primary and secondary substance misusers: Do they differ in substance-induced and substance-independent mental disorders?
    Bakken, K
    Landheim, AS
    Vaglum, P
    ALCOHOL AND ALCOHOLISM, 2003, 38 (01): : 54 - 59
  • [35] Clinical Application of Actigraphy in Psychotic Disorders: A Systematic Review
    Masoud Tahmasian
    Habibolah Khazaie
    Sanobar Golshani
    Kristin T. Avis
    Current Psychiatry Reports, 2013, 15
  • [36] Clinical Application of Actigraphy in Psychotic Disorders: A Systematic Review
    Tahmasian, Masoud
    Khazaie, Habibolah
    Golshani, Sanobar
    Avis, Kristin T.
    CURRENT PSYCHIATRY REPORTS, 2013, 15 (06)
  • [37] The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms
    Lechner, William V.
    Dahne, Jennifer
    Chen, Kevin W.
    Pickover, Alison
    Richards, Jessica M.
    Daughters, Stacey. B.
    Lejuez, C. W.
    DRUG AND ALCOHOL DEPENDENCE, 2013, 131 (1-2) : 78 - 84
  • [38] Comorbidity of Severe Psychotic Disorders With Measures of Substance Use
    Hartz, Sarah M.
    Pato, Carlos N.
    Medeiros, Helena
    Cavazos-Rehg, Patricia
    Sobell, Janet L.
    Knowles, James A.
    Bierut, Laura J.
    Pato, Michele T.
    JAMA PSYCHIATRY, 2014, 71 (03) : 248 - 254
  • [39] Substance use and sleep problems in patients with psychotic disorders
    Cederlof, E. V.
    Holm, M.
    Ahti, J.
    Lahteenvuo, M.
    Suvisaari, J.
    Lonnqvist, J.
    Kieseppa, T.
    Kampman, O.
    Hakkinen, K.
    Palotie, A.
    Tiihonen, J.
    Isometsa, E.
    Niemela, S.
    Paunio, T.
    JOURNAL OF SLEEP RESEARCH, 2022, 31
  • [40] SUBSTANCE-INDUCED ORGANIC MENTAL-DISORDERS
    TORNATORE, FL
    GILDERMAN, AM
    AMERICAN PHARMACY, 1982, 22 (09): : 43 - 46